Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$6.3M
Filings
89
Firms Hired
4
Active Period
2020–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Think Tank and Nonprofit Foreign Influence Disclosure Act
2026 · third_quarter · Firm: PHLOW CORPORATION
Administrations activities related to pharmaceutical supply chain and domestic capacity; Department of Health and Human Services activities related to pharmaceutical supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).
Client expense: $390,000 · Firm income: —
Matched citations: H.R.3966
Think Tank and Nonprofit Foreign Influence Disclosure Act
2026 · third_quarter · Firm: PHLOW CORPORATION
Administrations activities related to pharmaceutical supply chain and domestic capacity; Department of Health and Human Services activities related to pharmaceutical supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).
Client expense: $390,000 · Firm income: —
Matched citations: H.R.3966
Administrations activities related to pharmaceutical supply chain and domestic capacity; Department of Health and Human Services activities related to pharmaceutical supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).
Client expense: $390,000 · Firm income: —
Matched citations: H.R. 4191
Administrations activities related to pharmaceutical supply chain and domestic capacity; Department of Health and Human Services activities related to pharmaceutical supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).
Client expense: $390,000 · Firm income: —
Matched citations: H.R. 4191
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
2026 · third_quarter · Firm: PHLOW CORPORATION
FY27 Labor, Health and Human Services, Education, and Related Agencies Appropriations (H.R.9260); FY27 Department of Defense Appropriations (H.R.9495)
Client expense: $390,000 · Firm income: —
Matched citations: H.R.9260
Department of Defense Appropriations Act, 2027
2026 · third_quarter · Firm: PHLOW CORPORATION
FY27 Labor, Health and Human Services, Education, and Related Agencies Appropriations (H.R.9260); FY27 Department of Defense Appropriations (H.R.9495)
Client expense: $390,000 · Firm income: —
Matched citations: H.R.9495
Administrations activities related to pharmaceutical supply chain and domestic capacity; Department of Health and Human Services activities related to pharmaceutical supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).
Client expense: $390,000 · Firm income: —
Matched citations: S.1784
Administrations activities related to pharmaceutical supply chain and domestic capacity; Department of Health and Human Services activities related to pharmaceutical supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).
Client expense: $390,000 · Firm income: —
Matched citations: S.1784
Administrations activities related to pharmaceutical supply chain and domestic capacity; Department of Health and Human Services activities related to pharmaceutical supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).
Client expense: $390,000 · Firm income: —
Matched citations: S.2062
Administrations activities related to pharmaceutical supply chain and domestic capacity; Department of Health and Human Services activities related to pharmaceutical supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).
Client expense: $390,000 · Firm income: —
Matched citations: S.2062
Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to the National Defense Authorization Act for Fiscal Year 2026 (PL 119-60); Issues related to H.R. 4191/S. 1784 - MAPS Act; Issues related to H.R. 3955/S. 2062 - RAPID Reserve Act.
Client expense: — · Firm income: $90,000
Matched citations: H.R. 3955
Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to the National Defense Authorization Act for Fiscal Year 2026 (PL 119-60); Issues related to H.R. 4191/S. 1784 - MAPS Act; Issues related to H.R. 3955/S. 2062 - RAPID Reserve Act.
Client expense: — · Firm income: $90,000
Matched citations: H.R. 4191
Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to the National Defense Authorization Act for Fiscal Year 2026 (PL 119-60); Issues related to H.R. 4191/S. 1784 - MAPS Act; Issues related to H.R. 3955/S. 2062 - RAPID Reserve Act.
Client expense: — · Firm income: $90,000
Matched citations: S. 1784
Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to the National Defense Authorization Act for Fiscal Year 2026 (PL 119-60); Issues related to H.R. 4191/S. 1784 - MAPS Act; Issues related to H.R. 3955/S. 2062 - RAPID Reserve Act.
Client expense: — · Firm income: $90,000
Matched citations: S. 2062
Continuing Appropriations and Extensions Act, 2027
2026 · third_quarter · Firm: WESTMORELAND160, LLC
Department of Defense Appropriations Act, 2027 (H.R.9495; S.XXXX) (Provisions related to domestic supply chain for pharmaceuticals and Military health and Threat Reduction) Fiscal Year 2027 National Defense Authorization Act (H.R.8800; S.4784) (Provisions related to domestic supply chain for pharmaceuticals and Military health and Threat Reduction) FY2027 Continuing Appropriations and Extensions Act (H.R. 6500)
Client expense: — · Firm income: $45,000
Matched citations: H.R. 6500
Continuing Appropriations and Extensions Act, 2027
2026 · third_quarter · Firm: WESTMORELAND160, LLC
Department of Defense Appropriations Act, 2027 (H.R.9495; S.XXXX) (Provisions related to domestic supply chain for pharmaceuticals and Military health and Threat Reduction) Fiscal Year 2027 National Defense Authorization Act (H.R.8800; S.4784) (Provisions related to domestic supply chain for pharmaceuticals and Military health and Threat Reduction) FY2027 Continuing Appropriations and Extensions Act (H.R. 6500)
Client expense: — · Firm income: $45,000
Matched citations: H.R. 6500
National Defense Authorization Act for Fiscal Year 2027
2026 · third_quarter · Firm: WESTMORELAND160, LLC
Department of Defense Appropriations Act, 2027 (H.R.9495; S.XXXX) (Provisions related to domestic supply chain for pharmaceuticals and Military health and Threat Reduction) Fiscal Year 2027 National Defense Authorization Act (H.R.8800; S.4784) (Provisions related to domestic supply chain for pharmaceuticals and Military health and Threat Reduction) FY2027 Continuing Appropriations and Extensions Act (H.R. 6500)
Client expense: — · Firm income: $45,000
Matched citations: H.R.8800
National Defense Authorization Act for Fiscal Year 2027
2026 · third_quarter · Firm: WESTMORELAND160, LLC
Department of Defense Appropriations Act, 2027 (H.R.9495; S.XXXX) (Provisions related to domestic supply chain for pharmaceuticals and Military health and Threat Reduction) Fiscal Year 2027 National Defense Authorization Act (H.R.8800; S.4784) (Provisions related to domestic supply chain for pharmaceuticals and Military health and Threat Reduction) FY2027 Continuing Appropriations and Extensions Act (H.R. 6500)
Client expense: — · Firm income: $45,000
Matched citations: H.R.8800
Department of Defense Appropriations Act, 2027
2026 · third_quarter · Firm: WESTMORELAND160, LLC
Department of Defense Appropriations Act, 2027 (H.R.9495; S.XXXX) (Provisions related to domestic supply chain for pharmaceuticals and Military health and Threat Reduction) Fiscal Year 2027 National Defense Authorization Act (H.R.8800; S.4784) (Provisions related to domestic supply chain for pharmaceuticals and Military health and Threat Reduction) FY2027 Continuing Appropriations and Extensions Act (H.R. 6500)
Client expense: — · Firm income: $45,000
Matched citations: H.R.9495
Department of Defense Appropriations Act, 2027
2026 · third_quarter · Firm: WESTMORELAND160, LLC
Department of Defense Appropriations Act, 2027 (H.R.9495; S.XXXX) (Provisions related to domestic supply chain for pharmaceuticals and Military health and Threat Reduction) Fiscal Year 2027 National Defense Authorization Act (H.R.8800; S.4784) (Provisions related to domestic supply chain for pharmaceuticals and Military health and Threat Reduction) FY2027 Continuing Appropriations and Extensions Act (H.R. 6500)
Client expense: — · Firm income: $45,000
Matched citations: H.R.9495
National Defense Authorization Act for Fiscal Year 2027
2026 · third_quarter · Firm: WESTMORELAND160, LLC
Department of Defense Appropriations Act, 2027 (H.R.9495; S.XXXX) (Provisions related to domestic supply chain for pharmaceuticals and Military health and Threat Reduction) Fiscal Year 2027 National Defense Authorization Act (H.R.8800; S.4784) (Provisions related to domestic supply chain for pharmaceuticals and Military health and Threat Reduction) FY2027 Continuing Appropriations and Extensions Act (H.R. 6500)
Client expense: — · Firm income: $45,000
Matched citations: S.4784
National Defense Authorization Act for Fiscal Year 2027
2026 · third_quarter · Firm: WESTMORELAND160, LLC
Department of Defense Appropriations Act, 2027 (H.R.9495; S.XXXX) (Provisions related to domestic supply chain for pharmaceuticals and Military health and Threat Reduction) Fiscal Year 2027 National Defense Authorization Act (H.R.8800; S.4784) (Provisions related to domestic supply chain for pharmaceuticals and Military health and Threat Reduction) FY2027 Continuing Appropriations and Extensions Act (H.R. 6500)
Client expense: — · Firm income: $45,000
Matched citations: S.4784
Think Tank and Nonprofit Foreign Influence Disclosure Act
2026 · second_quarter · Firm: PHLOW CORPORATION
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).
Client expense: $370,000 · Firm income: —
Matched citations: H.R.3966
Think Tank and Nonprofit Foreign Influence Disclosure Act
2026 · second_quarter · Firm: PHLOW CORPORATION
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).
Client expense: $370,000 · Firm income: —
Matched citations: H.R.3966
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).
Client expense: $370,000 · Firm income: —
Matched citations: H.R. 4191
Source: Senate LDA